Studies on the effect of glucagon on human pancreatic secretion by analysis of endoscopically obtained pure pancreatic juice.
The effect of glucagon on human exocrine pancreatic secretion was evaluated in ten patients by analysis of pure pancreatic juice. Pancreatic juice was obtained by endoscopic cannulation of the pancreatic duct at 2-min intervals during constant intravenous infusion of secretin (1 U per kg of body weight per hr) plus caerulein (0.04 micrograms per kg of body weight per hr). Since steady secretion was established 20 minutes after the start of juice collection, a further five 2-min fractions were collected as controls, then constant intravenous infusion of glucagon (15 micrograms per kg of body weight per hr) was commenced. Pancreatic juice was collected for a further 20 minutes. The control fractions and post-glucagon fractions were compared in each patient using Student's test. Glucagon depressed secretin-caerulein-stimulated pancreatic secretions. More uniform reductions were observed in the concentration and output of protein and enzymes. Individual variations were observed in the secretory volume and bicarbonate concentration and output. Amylase and lipase were depressed in a parallel fashion in seven patients and in the remaining three, amylase was more depressed than lipase. The post-glucagon reduction in pancreatic secretion was not proportional to the rise in plasma glucagon and blood glucose.
D000230:Adenocarcinoma / Q000503:physiopathology; D000328:Adult; D000368:Aged; D002108:Ceruletide; D002908:Chronic Disease; D003864:Depression, Chemical; D005260:Female; D005934:Glucagon / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010179:Pancreas / Q000187:drug effects* / Q000378:metabolism; D010189:Pancreatic Juice / Q000187:drug effects* / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000503:physiopathology; D010195:Pancreatitis / Q000503:physiopathology; D012633:Secretin; D012636:Secretory Rate / Q000187:drug effects; D013997:Time Factors
D012633:Secretin; D002108:Ceruletide; D005934:Glucagon